Taku Miyagawa Selected Research

Carnitine O-Palmitoyltransferase (Carnitine Palmitoyltransferase II)

10/2022	Low carnitine palmitoyltransferase 1 activity is a risk factor for narcolepsy type 1 and other hypersomnia.
11/2019	Thermolabile polymorphism of carnitine palmitoyltransferase 2: A genetic risk factor of overall acute encephalopathy.
10/2016	Evaluation of polygenic risks for narcolepsy and essential hypersomnia.
1/2013	Effects of oral L-carnitine administration in narcolepsy patients: a randomized, double-blind, cross-over and placebo-controlled trial.
3/2011	Abnormally low serum acylcarnitine levels in narcolepsy patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Taku Miyagawa Research Topics

Disease

20	Narcolepsy 10/2022 - 11/2008
10	Cataplexy 01/2020 - 11/2008
9	Disorders of Excessive Somnolence (Hypersomnia) 10/2022 - 01/2009
4	Sleep Wake Disorders 01/2020 - 11/2008
3	Idiopathic Hypersomnia 04/2022 - 07/2010
3	Autism Spectrum Disorder 01/2016 - 03/2010
2	Panic Disorder (Panic Attack) 01/2016 - 05/2015
2	Schizophrenia (Dementia Praecox) 02/2015 - 09/2013
2	Sleepiness 01/2013 - 11/2008
1	Apnea 11/2020
1	Brain Diseases (Brain Disorder) 11/2019
1	Sleep Paralysis 01/2019
1	Hallucinations (Hallucination) 01/2019
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2016
1	Neurodevelopmental Disorders 01/2015
1	Psychotic Disorders (Schizoaffective Disorder) 09/2013
1	Mental Disorders (Mental Disorder) 03/2011
1	Drug-Related Side Effects and Adverse Reactions 01/2008

Drug/Important Bio-Agent (IBA)

7	OrexinsIBA 06/2022 - 11/2008
7	HLA-DQB1 antigen (HLA DQB1)IBA 12/2018 - 11/2008
6	HLA-DRB1 Chains (HLA DRB1)IBA 01/2016 - 11/2008
5	Carnitine O-Palmitoyltransferase (Carnitine Palmitoyltransferase II)IBA 10/2022 - 03/2011
5	HLA Antigens (Human Leukocyte Antigens)IBA 12/2018 - 07/2010
4	T-Cell Antigen Receptors (T-Cell Receptor)IBA 10/2016 - 06/2009
3	Fatty Acids (Saturated Fatty Acids)IBA 10/2022 - 03/2011
3	Oxytocin Receptors (Oxytocin Receptor)IBA 01/2016 - 03/2010
2	NeuropeptidesIBA 01/2019 - 05/2014
2	Purinergic Receptors (Receptors, Purine)IBA 10/2016 - 01/2011
2	Carnitine (L-Carnitine)FDA LinkGeneric 01/2013 - 03/2011
2	acylcarnitineIBA 01/2013 - 03/2011
2	Genetic Markers (Genetic Marker)IBA 01/2010 - 01/2009
1	5'-methylthioadenosineIBA 11/2020
1	DNA (Deoxyribonucleic Acid)IBA 01/2020
1	Unithiol (DMPS)IBA 01/2018
1	AcidsIBA 01/2018
1	Hormones (Hormone)IBA 01/2018
1	CXCR3 ReceptorsIBA 01/2017
1	GTP-Binding Proteins (G-Protein)IBA 10/2016
1	CC ChemokinesIBA 10/2015
1	Antipsychotic Agents (Antipsychotics)IBA 02/2015
1	Methamphetamine (Desoxyn)FDA LinkGeneric 09/2013
1	EnzymesIBA 01/2013
1	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 03/2011
1	Messenger RNA (mRNA)IBA 03/2011
1	3' Untranslated Regions (3' UTR)IBA 01/2011
1	AutoantibodiesIBA 07/2010
1	AntigensIBA 07/2010
1	HLA-DR2 Antigen (HLA DR2 Antigen)IBA 06/2009
1	Arylamine N-AcetyltransferaseIBA 01/2008